Day: February 7, 2024

MIAMI, Feb. 07, 2024 (GLOBE NEWSWIRE) — PennantPark Floating Rate Capital Ltd. (NYSE: PFLT) (TASE: PFLT) announced today its financial results for the first quarter ended December 31, 2023. HIGHLIGHTS Quarter ended December 31, 2023 (Unaudited) ($ in millions, except per share amounts)Assets and Liabilities:          Investment portfolio (1)       $ 1,270.9  Net assets       $ 658.0  GAAP net asset value per share       $ 11.20  Quarterly increase in GAAP net asset value per share         0.6 %Adjusted net asset value per share (2)       $ 11.20  Quarterly increase in adjusted net asset value per share (2)         0.6 %                      Credit Facility       $ 260.9  2026 Notes       $ 183.2  2031 Asset-Backed Debt       $ 226.9  Regulatory debt to equity       1.03x  Weighted average...

Annualized recurring revenue (“ARR”) of $806 million, an increase of 13% year-over-year Full-year revenue of $778 million, up 14% year-over-year; Products revenue of $740 million, up 14% year-over-year Full-year GAAP operating loss of $81 million; Full-year non-GAAP operating income of $102 million Full-year net cash provided by operating activities of $104 million; Free cash flow of $84 millionBOSTON, Feb. 07, 2024 (GLOBE NEWSWIRE) — Rapid7, Inc. (Nasdaq: RPD), a leader in extended risk and threat detection, today announced its financial results for the fourth quarter and full-year 2023. “Rapid7 delivered solid results to end the year, exceeding our guided ranges on ARR, revenue, non-GAAP operating income, and free cash flow. Mainstream enterprise customers continue to choose Rapid7 for the strength of our consolidated security...

WHITTIER, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) — First Pacific Bancorp (the “Company”) (OTC Pink: FPBC), the holding company for First Pacific Bank (the “Bank”), today reported consolidated results for the fourth quarter and year ending December 31, 2023. The Company continues to maintain a strong capital and liquidity position, centered on a solid, stable core deposit base, and access to significant sources of liquidity. Key highlights for the fourth quarter and full year 2023 include:Total assets ended Q4 2023 at $420 million, up $53 million from $367 million at year end 2022. Total deposits ended the fourth quarter at $333 million, up $68 million since year end 2022. Total loans ended the fourth quarter at $275 million, up $70 million since year end 2022. Asset quality remains excellent, and we have experienced no significant...

– First quarter fiscal 2024 revenue up 10.3% to $135.5 million – First quarter fiscal 2024 DSA revenue up 8.8% to $44.7 million and RMS revenue up 11.1% to $90.8 million – Shift to a renewed focus on sales and marketing as near-term infrastructure projects near completion – Conference call begins today at 4:30 pm ET WEST LAFAYETTE, Ind., Feb. 07, 2024 (GLOBE NEWSWIRE) — Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced financial results for the three months (“Q1 FY 2024”) ended December 31, 2023. Revenue by Segment(in millions of USD) Three months endedDecember 31   %change    2023     2022      (unaudited)   (unaudited)    DSA(Discovery...

TULSA, Okla., Feb. 07, 2024 (GLOBE NEWSWIRE) — Matrix Service Company (Nasdaq: MTRX), through its subsidiaries, is a leading North American industrial engineering, construction, and maintenance contractor headquartered in Tulsa, Oklahoma with offices located throughout the United States and Canada, as well as Sydney, Australia and Seoul, South Korea. Key highlights:Backlog increased to $1.45 billion, the highest level in the company’s history; project awards in the quarter of $230.8 million resulted in a book-to-bill ratio of 1.3. Revenue of $175.0 million in the second quarter of fiscal 2024. Direct gross margins have returned to historical double-digit levels in the first half of fiscal 2024; impact of under-recovery is expected to resolve as revenue volumes increase. Adjusted EBITDA of $0.3 million(1) for the second...

KIRKLAND, Wash., Feb. 07, 2024 (GLOBE NEWSWIRE) — Monolithic Power Systems, Inc. (“MPS”) (Nasdaq: MPWR), a fabless global company that provides high-performance, semiconductor-based power electronics solutions, today announced financial results for the quarter and year ended December 31, 2023. MPS also announced that its Board of Directors has approved an increase in the quarterly cash dividend from $1.00 per share to $1.25 per share. The first quarter dividend of $1.25 per share will be paid on April 15, 2024 to all stockholders of record as of the close of business on March 29, 2024. The financial results for the quarter ended December 31, 2023 were as follows:● Revenue was $454.0 million for the quarter ended December 31, 2023, a 4.4% decrease from $474.9 million for the quarter ended September 30, 2023 and a 1.3% decrease...

ARLINGTON, Va., Feb. 07, 2024 (GLOBE NEWSWIRE) — Fluence Energy, Inc. (Nasdaq: FLNC) (“Fluence” or the “Company”), a leading global pure-play provider of energy storage products and services as well as digital applications for renewables and storage, today announced its results for the three months ended December 31, 2023. Financial Highlights for First Fiscal Quarter ending December 31, 2023Quarterly revenue of approximately $364.0 million, which represents an increase of 17% from the same quarter last year. GAAP gross profit margin improved to approximately 10.0%, compared to approximately 3.9% for the same quarter last year. Adjusted gross profit margin1 improved to approximately 10.5%, compared to approximately 4.2% for the same quarter last year. Net loss of approximately $25.6 million, compared to approximately $37.2 million...

Announced new non-exclusive data license with GSK, introduced 23andMe Total Health™, and received FDA clearance for IND on novel, dual-mechanism immuno-oncology asset 23ME-1473 SOUTH SAN FRANCISCO, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and biopharmaceutical company, reported its financial results for the third quarter of fiscal year 2024 (FY24), which ended December 31, 2023. Key ResultsReported total revenue of $44.7 million in the third quarter of fiscal 2024, compared to $66.9 million in the third quarter of fiscal 2023, a decrease of approximately 33% due to lower research revenue after the conclusion of the GSK collaboration exclusivity term in July 2023 and lower PGS kit volumes. Announced a non-exclusive data license with GSK plc (LSE/NYSE: GSK) for novel...

Launch of TransCon™ PTH underway with full commercial availability in Germany and Austria; U.S. PDUFA date of May 14, 2024 TransCon CNP pivotal ApproaCH Trial on track for topline results in Q4 2024 Total Q4 revenue of €138 million including SKYTROFA® revenue of €64 million; Q4 operating expenses of €155 million Conference call today at 4:30 pm ETCOPENHAGEN, Denmark, Feb. 07, 2024 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced financial results for the fourth quarter and full year ended December 31, 2023 and provided a business update. “In 2023, we streamlined Ascendis, including our structure, processes, and operating expense allocation, and at the same time we believe we remain on track to achieve Vision 3×3,” said Jan Mikkelsen, Ascendis Pharma’s President and Chief Executive Officer. “SKYTROFA...